Literature DB >> 12627667

Disseminated intravascular coagulation current concepts of etiology, pathophysiology, diagnosis, and treatment.

Rodger L Bick1.   

Abstract

The pathophysiologic mechanisms and clinical and laboratory manifestations of DIC are complex, partly because of inter-relationships within the hemostasis system. Only by clearly understanding these extraordinarily complex pathophysiologic inter-relationships can the clinician and laboratory scientist appreciate the divergent and wide spectrum of often-confusing clinical and laboratory findings in patients with DIC. Many therapeutic decisions to be made are controversial and lack validation. Nevertheless, newer antithrombotic agents and agents that can block, blunt, or modify cytokine activity and the activity of vasoactive substances seem to be of value. The complexity and variable degree of clinical expression suggest that therapy should be individualized depending on the nature of DIC, the patient's age, etiology of DIC, site and severity of hemorrhage or thrombosis, and hemodynamics and other appropriate clinical parameters.

Entities:  

Mesh:

Year:  2003        PMID: 12627667     DOI: 10.1016/s0889-8588(02)00102-8

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  11 in total

1.  Successful treatment of sepsis-induced disseminated intravascular coagulation in a patient with idiopathic thrombocytopenic purpura using recombinant human soluble thrombomodulin.

Authors:  Tomohiro Koga; Daisuke Inoue; Akitomo Okada; Toshiyuki Aramaki; Satoshi Yamasaki; Munetoshi Nakashima; Atsushi Kawakami; Katsumi Eguchi
Journal:  Rheumatol Int       Date:  2011-01-15       Impact factor: 2.631

2.  Aortic aneurysm and chronic disseminated intravascular coagulation: a retrospective study of 235 patients.

Authors:  Yun Zhang; Chen Li; Min Shen; Bao Liu; Xuejun Zeng; Ti Shen
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

3.  Recombinant human antithrombin expressed in the milk of non-transgenic goats exhibits high efficiency on rat DIC model.

Authors:  Hai Yang; Qing-Wang Li; Zeng-Sheng Han; Jian-Hong Hu; Wen-Ye Li; Zhi-Bin Liu
Journal:  J Thromb Thrombolysis       Date:  2009-05-20       Impact factor: 2.300

Review 4.  Identifying oncological emergencies.

Authors:  Achuta K Guddati; Nilay Kumar; Ankur Segon; Parijat S Joy; Creticus P Marak; Gagan Kumar
Journal:  Med Oncol       Date:  2013-07-20       Impact factor: 3.064

5.  DIC Score: Statistical Relationship with PT, APTT, and Simplified Scoring Systems with Combinations of PT and APTT.

Authors:  Vani Chandrashekar
Journal:  ISRN Hematol       Date:  2012-03-05

6.  Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation.

Authors:  Massimo Franchini; Giuseppe Lippi; Franco Manzato
Journal:  Thromb J       Date:  2006-02-21

7.  Management of Chronic Disseminated Intravascular Coagulation Associated with Aortic Aneurysm/Dissection.

Authors:  Shigeru Koba; Tomoya Yamaguchi; Kenji Miki; Hiroshi Makihara; Shinsaku Imashuku
Journal:  Case Rep Hematol       Date:  2019-04-02

8.  Coagulopathy in patients who experience snakebite.

Authors:  Jae Seok Kim; Jae Won Yang; Min Soo Kim; Seung Tae Han; Bi Ro Kim; Myung Sang Shin; Jong In Lee; Byoung Geun Han; Seung Ok Choi
Journal:  Korean J Intern Med       Date:  2008-06       Impact factor: 2.884

9.  Treatment effects of xuebijing injection in severe septic patients with disseminated intravascular coagulation.

Authors:  Qin Yin; Chunsheng Li
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-23       Impact factor: 2.629

10.  Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.

Authors:  Miyuki Ookura; Naoko Hosono; Toshiki Tasaki; Kana Oiwa; Kei Fujita; Kazuhiro Ito; Shin Lee; Yasufumi Matsuda; Mihoko Morita; Katsunori Tai; Eiju Negoro; Shinji Kishi; Hiromichi Iwasaki; Takanori Ueda; Takahiro Yamauchi
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.